Phase 1 Dose- Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukaemias

The prognosis of patients with relapsed and refractory acute leukaemia (RRAL) is very poor. Forty patients with RRAL were enrolled (28 acute myeloid leukaemia [AML], 12 acute lymphoblastic leukaemia [ALL]) in this Phase 1 dose-escalation trial of daily-infused clofarabine (CLO) followed by cyclophos...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Zeidan, Amer M, Ricklis, Rebecca M, Carraway, Hetty E, Yun, Hyun D, Greer, Jacqueline M, Smith, B Douglas, Levis, Mark J, McDevitt, Michael A, Pratz, Keith W, Showel, Margaret M, Gladstone, Douglas E, Gore, Steven D, Karp, Judith E
Формат: Artigo
Язык:Inglês
Опубликовано: 2012
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3389586/
https://ncbi.nlm.nih.gov/pubmed/22594769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2012.09142.x
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы